Beyond its direct expression on AML cells to promote tumor immune escape, VISTA is also highly expressed on MDSC in the peripheral blood of AML patients, and specific knockdown of VISTA effectively reduces the inhibition of CD8+ T cell activity by MDSCs and promotes anti-tumor responses [97]. Here, VSIR is linked to acute myeloid leukemia.